A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00087724. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 2 Study to Evaluate the Safety and Efficacy of FK962 in Subjects With Mild to Moderate Alzheimer's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and efficacy of five fixed dosage levels of FK962 or placebo for 24 weeks in subjects with mild to moderate Alzheimer's disease. Patient visits are every six weeks with limited efficacy measurements at week 6 and 18.
Study identification
- NCT ID
- NCT00087724
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 510 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2004 (Type not available)
- Primary completion
- Not listed
- Completion
- Sep 2006 (Actual)
- Last update posted
- Jun 7, 2012
2004 – 2006
United States locations
- U.S. sites
- 72
- U.S. states
- 31
- U.S. cities
- 66
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site | Phoenix | Arizona | 85013 | — |
| Investigational Site | Phoenix | Arizona | 85032 | — |
| Not listed | Sun City | Arizona | 85351 | — |
| Investigational Site | Tucson | Arizona | 85724 | — |
| Investigational Site | Little Rock | Arkansas | 72205 | — |
| Investigational Site | Little Rock | Arkansas | 72211 | — |
| Investigational Site | Fresno | California | 93720 | — |
| Investigational Site | Irvine | California | 92618 | — |
| Investigational Site | Orange | California | 92656 | — |
| Investigational Site | San Francisco | California | 94115 | — |
| Investigational Site | Sherman Oaks | California | 91403 | — |
| Investigational Site | Torrance | California | 90505 | — |
| Investigative Site | Denver | Colorado | 80249 | — |
| Investigational Site | Denver | Colorado | 80262 | — |
| Investigational Site | Darien | Connecticut | 06820 | — |
| Investigational Site | Hamden | Connecticut | 06518 | — |
| Not listed | Hamden | Connecticut | 06518 | — |
| Investigational Site | Stamford | Connecticut | 06902 | — |
| Investigational Site | Fort Myers | Florida | 33912 | — |
| Investigational Site | Hialeah | Florida | 33016 | — |
| Investigational Site | Hollywood | Florida | 33021 | — |
| Investigational Site | Miami | Florida | 33176 | — |
| Investigational Site | North Miami | Florida | 33161 | — |
| Investigational Site | Ocala | Florida | 34471 | — |
| Investigational Site | Port Charlotte | Florida | 33952 | — |
| Investigational Site | Sarasota | Florida | 34243 | — |
| Investigational Site | Sebring | Florida | 33872 | — |
| Investigational Site | Tampa | Florida | 33613 | — |
| Not listed | West Palm Beach | Florida | 33407 | — |
| Investigational Site | Snellville | Georgia | 30078 | — |
| Not listed | Snellville | Georgia | 30078 | — |
| Investigational Site | Elk Grove | Illinois | 60007 | — |
| Investigational Site | Wichita | Kansas | 67207 | — |
| Investigational Site | New Orleans | Louisiana | 70112 | — |
| Not listed | Baltimore | Maryland | 21208 | — |
| Investigational Site | Newton | Massachusetts | 02459 | — |
| Not listed | Livonia | Michigan | 48152 | — |
| Not listed | Hattiesburg | Mississippi | 32401 | — |
| Investigational Site | St Louis | Missouri | 63128 | — |
| Investigational Site | Las Vegas | Nevada | 89102 | — |
| Investigational Site | Long Branch | New Jersey | 07740 | — |
| Investigational Site | Paterson | New Jersey | 08759 | — |
| Investigational Site | Piscataway | New Jersey | 08855 | — |
| Investigational Site | Albuquerque | New Mexico | 87102 | — |
| Investigational Site | Albany | New York | 12208 | — |
| Investigational Site | Buffalo | New York | 14221 | — |
| Investigational Site | Lawrence | New York | 11559 | — |
| Investigational Site | New York | New York | 10021 | — |
| Investigational Site | White Plains | New York | 10605 | — |
| Not listed | Charlotte | North Carolina | 28204 | — |
| Investigational Site | Centerville | Ohio | 45459 | — |
| Investigational Site | Columbus | Ohio | 43210 | — |
| Not listed | Dayton | Ohio | 45408 | — |
| Investigational Site | Dayton | Ohio | 45415 | — |
| Investigational Site | Toledo | Ohio | 43623 | — |
| Investigational Site | Oklahoma City | Oklahoma | 73112 | — |
| Investigational Site | Tulsa | Oklahoma | 74104 | — |
| Investigational Site | Eugene | Oregon | 97401 | — |
| Investigational Site | Medford | Oregon | 97504 | — |
| Investigational Site | Bala-Cynwyd | Pennsylvania | 19004 | — |
| Investigational Site | Jenkintown | Pennsylvania | 19046 | — |
| Investigational Site | Pawtucket | Rhode Island | 02860 | — |
| Investigational Site | Johnson City | Tennessee | 37601 | — |
| Investigational Site | Nashville | Tennessee | 37203 | — |
| Investigational Site | Houston | Texas | 77063 | — |
| Investigational Site | San Antonio | Texas | 78229 | — |
| Investigational Site | Wichita Falls | Texas | 76309 | — |
| Investigational Site | Salt Lake City | Utah | 84121 | — |
| Investigational Site | Bennington | Vermont | 05201 | — |
| Not listed | Burlington | Vermont | 05401 | — |
| Investigational Site | Norfolk | Virginia | 23507 | — |
| Investigational Site | Milwaukee | Wisconsin | 53227 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00087724, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 7, 2012 · Synced Nov 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.